CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

April 15, 2024

https://www.globenewswire.com/news-release/2024/04/15/2863155/0/en/CARGO-Therapeutics-Names-Kapil-Dhingra-M-B-B-S-to-Board-of-Directors.html

SAN MATEO, Calif., April 15, 2024 (GLOBE NEWSWIRE) — CARGO Therapeutics, Inc. (Nasdaq:CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced it has appointed Kapil Dhingra, M.B.B.S., to the Company’s Board of Directors. Dr. Dhingra is a medical oncologist and a physician-scientist bringing more than 25 years of strategic clinical development experience in oncology, including cell therapy, with a proven track record in drug development, patient care and academic research.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.